Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA clears AI-powered AFib monitor, gives boost to new HF treatment | CT's role in coronary interventions
Tuesday, July 26, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Regulatory Roundup: FDA clears AI-powered Apple Watch competitor, grants breakthrough designation to new heart failure device

Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.

READ MORE >
Ancora Heart AccuCinch Ventricular Restoration System heart failure FDA
Share on Twitter Share on Facebook Share on Linkedin

Regulatory Roundup: FDA clears AI-powered Apple Watch competitor, grants breakthrough designation to new heart failure device

Share on Twitter Share on Facebook Share on Linkedin
Ancora Heart AccuCinch Ventricular Restoration System heart failure FDA
Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.
READ MORE >

VIDEO: CT imaging to plan coronary interventions — Interview with Jonathon Leipsic, MD

Jonathon Leipsic, MD, chairman of the Department of Radiology, University of British Columbia, explains how noninvasive computed tomography angiography (CTA) can be used to aid in planning interventional cardiology procedures for percutaneous coronary intervention (PCI) and chronic total occlusions (CTO). 

READ MORE >
Example of a patient's coronary tree extracted from a cardiac CT scan. CT allows very detailed anatomical imaging and now physiological and plaque information that can be useful in pre-planning interventional procedures. Imaging from the GE Revolution Apex system at SCCT 2022.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: CT imaging to plan coronary interventions — Interview with Jonathon Leipsic, MD

Share on Twitter Share on Facebook Share on Linkedin
Example of a patient's coronary tree extracted from a cardiac CT scan. CT allows very detailed anatomical imaging and now physiological and plaque information that can be useful in pre-planning interventional procedures. Imaging from the GE Revolution Apex system at SCCT 2022.
Jonathon Leipsic, MD, chairman of the Department of Radiology, University of British Columbia, explains how noninvasive computed tomography angiography (CTA) can be used to aid in planning interventional cardiology procedures for percutaneous coronary intervention (PCI) and chronic total occlusions (CTO). 
READ MORE >

What new research tells us about the significant heart damage associated with COVID-19

“We found direct evidence that the SARS-CoV-2 spike protein is toxic to heart muscle cells," one researcher said. 

READ MORE >
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
Share on Twitter Share on Facebook Share on Linkedin

What new research tells us about the significant heart damage associated with COVID-19

Share on Twitter Share on Facebook Share on Linkedin
patient_exam_cardiology_covid_dr_cowan_beaumont.jpeg
“We found direct evidence that the SARS-CoV-2 spike protein is toxic to heart muscle cells," one researcher said. 
READ MORE >

Featured Articles

VIDEO: Why plaque composition CT imaging may be the future of cardiology

Former European Society of Cardiology president Prof. Jeroen Bax explains the difficulty in quantifying these plaques manually and how artificial intelligence may change this to allow rapid, detailed quantitative analysis. 

READ MORE >
AI-generated coronary tree from a patient's CT scan showing a color code of areas of interest for plaque burden from the Cleerly software shown at SCCT 2022.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Why plaque composition CT imaging may be the future of cardiology

Share on Twitter Share on Facebook Share on Linkedin
AI-generated coronary tree from a patient's CT scan showing a color code of areas of interest for plaque burden from the Cleerly software shown at SCCT 2022.
Former European Society of Cardiology president Prof. Jeroen Bax explains the difficulty in quantifying these plaques manually and how artificial intelligence may change this to allow rapid, detailed quantitative analysis. 
READ MORE >

The power of potassium: Bananas, avocados and salmon boost heart health among women

Eating a potassium-rich diet can help women lower their blood pressure and reduce their risk of cardiovascular events by a significant margin, according to a new study of more than 25,000 adults.

READ MORE >
banana potassium cardiovascular disease European Society of Cardiology
Share on Twitter Share on Facebook Share on Linkedin

The power of potassium: Bananas, avocados and salmon boost heart health among women

Share on Twitter Share on Facebook Share on Linkedin
banana potassium cardiovascular disease European Society of Cardiology
Eating a potassium-rich diet can help women lower their blood pressure and reduce their risk of cardiovascular events by a significant margin, according to a new study of more than 25,000 adults.
READ MORE >

High blood pressure more than doubles risk of COVID-19 hospitalization

Adults that received three doses of an mRNA COVID vaccine were 2.6 times as likely to be hospitalized if they also had high blood pressure. 

READ MORE >
Blood pressure
Share on Twitter Share on Facebook Share on Linkedin

High blood pressure more than doubles risk of COVID-19 hospitalization

Share on Twitter Share on Facebook Share on Linkedin
Blood pressure
Adults that received three doses of an mRNA COVID vaccine were 2.6 times as likely to be hospitalized if they also had high blood pressure. 
READ MORE >

Using a TAVR-like minimalist approach for valve-in-valve TMVR is safe and effective, Cleveland Clinic study confirms

During valve-in-valve TMVR, patients are treated with conscious sedation or monitored anesthesia care instead of general anesthesia. This new analysis confirms that the change does not impact patient outcomes, but it was linked to a shorter length of stay.

READ MORE >
Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

Using a TAVR-like minimalist approach for valve-in-valve TMVR is safe and effective, Cleveland Clinic study confirms

Share on Twitter Share on Facebook Share on Linkedin
Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.
During valve-in-valve TMVR, patients are treated with conscious sedation or monitored anesthesia care instead of general anesthesia. This new analysis confirms that the change does not impact patient outcomes, but it was linked to a shorter length of stay.
READ MORE >

In Other News

Patient privacy concerns are rising

92% of patients believe privacy is a right and their health data should not be available for purchase by corporations or other individuals.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Patient privacy concerns are rising

Share on Twitter Share on Facebook Share on Linkedin
92% of patients believe privacy is a right and their health data should not be available for purchase by corporations or other individuals.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme